On May 29, 2024, Bruker Corporation entered into an underwriting agreement with BofA Securities and J.P. Morgan Securities for a public offering of 6 million shares of common stock. The underwriters agreed to purchase the shares at $67.29 per share, with an additional option to acquire up to 900,000 shares within a 30-day period.The offering was made through an automatically effective registration statement on Form S-3 filed with the SEC on May 29, 2024. The agreement includes customary representations, warranties, and indemnification obligations between the parties. The company announced the launch and pricing of the offering through press releases on the same day.

On May 29, 2024, Bruker Corporation entered into an underwriting agreement with BofA Securities and J.P. Morgan Securities for a public offering of 6 million shares of common stock. The underwriters agreed to purchase the shares at $67.29 per share, with an additional option to acquire up to 900,000 shares within a 30-day period.The offering was made through an automatically effective registration statement on Form S-3 filed with the SEC on May 29, 2024. The agreement includes customary representations, warranties, and indemnification obligations between the parties. The company announced the launch and pricing of the offering through press releases on the same day.